Delivery Order SPE2DB24D2101-SPE2DB24FKFKF

Award Date 7/22/24
Potential Completion Date 7/23/24
Potential Value $80K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,031.72, is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, worth up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,169.81 Firm Fixed Price Delivery Order contract is for the provision of BETASERON 0.3 MG KITS, a pharmaceutical product. The contract has an ultimate completion date of October 11, 2023 and was awarded on October 10, 2023. This award is associated with a larger $999,999,999 Indefinite...
This federal contract award, valued at $22,162.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BETASERON 0.3 MG KITS, a pharmaceutical product, with a completion date of May 8, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
The Defense Logistics Agency has awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a firm fixed price delivery order contract valued at $9,790.63 to provide BETASERON 0.3 MG KITS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp...
This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of BETASERON 0.3 MG KITS, a pharmaceutical product, with a ceiling value of $17,224.47 and a period of performance through June 18, 2025. The contract is a firm fixed-price contract and is not set aside for any socioeconomic program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $55,890.92, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of BETASERON 0.3 MG KITS, a pharmaceutical product, with a completion date of January 4, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,081.08 firm fixed-price delivery order is for the supply of BETASERON 0.3 MG KITS, a medication used in the treatment of multiple sclerosis. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,400.72 firm-fixed-price delivery order is for the supply of BETASERON 0.3 MG KITS, a specialized medication. The contract has a June 22, 2023 completion date and was awarded on June 21, 2023. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,326.46, is for the supply of BETASERON 0.3 MG KITS, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $5,536.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Betaseron 0.3 mg kits, a specialty medication, to support military and government healthcare programs. The award was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains a...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB24FKFKF
    Delivery Order

This federal contract award, valued at $80,285.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026.

The contract provides for the delivery of BETASERON 0.3 MG KITS, a pharmaceutical product, to support military healthcare programs. This award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and there are no major subcontractors listed. The contract has an ultimate completion date of July 23, 2024.

Generated 5/17/25, 9:47 AM